HLA-C and neoplasm: Second, RT induces transient expression of MHC/peptide complexes on tumor stromal cells by activating the mTOR pathway, these newly generated peptides bind to MHC I and are presented on the surface of tumor cells, significantly enhancing their immunogenicity [117, 118].